The discovery and clinical application of insulin as well as the subsequent introduction of various oral hypoglycemic agents (OHAs) have greatly prolonged the survival time of T2DM patients and transformed T2DM into a major chronic non-communicable disease. This evidence concerns the gene INS and type 2 diabetes mellitus.